[
  {
    "question_id": "expert_interviews_43_q1",
    "model_answer": "answer: Unable to answer\n\nThe provided audio does not contain any information about clinical trial protocols, clinicaltrials.gov, or the transparency of clinical research programs. Therefore, it's impossible to determine which events/sub-events might have led to the concrete transparency step mentioned in the question.",
    "choices": [
      "Unable to answer"
    ]
  },
  {
    "question_id": "expert_interviews_43_q2",
    "model_answer": "answer: Unable to answer\n\nThe provided audio does not contain any information related to the decision to waive IP rights on an HIV medicine in Africa or the preceding events that might have contributed to such a decision. The audio content is focused on collaboration, transparency, and health literacy but does not mention anything about IP rights or HIV medicines. Therefore, it's impossible to determine which events might have led to the decision based solely on the given audio.",
    "choices": [
      "Unable to answer"
    ]
  }
]